CD14 and B-cell chronic lymphocytic leukemia: We next wanted to orthogonally validate that the impact of CSF1R inhibition on CLL cell viability is due to the presence (or, rather, the post-inhibitor depletion) of CSF1R-expressing CD14-positive cells.